SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-017287
Filing Date
2022-11-10
Accepted
2022-11-10 07:30:47
Documents
96
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ipsc-20220930x10q.htm   iXBRL 10-Q 2357671
2 EX-10.1 ipsc-20220930xex10d1.htm EX-10.1 37424
3 EX-31.1 ipsc-20220930xex31d1.htm EX-31.1 12641
4 EX-31.2 ipsc-20220930xex31d2.htm EX-31.2 12483
5 EX-32.1 ipsc-20220930xex32d1.htm EX-32.1 6211
6 EX-32.2 ipsc-20220930xex32d2.htm EX-32.2 6205
  Complete submission text file 0001558370-22-017287.txt   9377757

Data Files

Seq Description Document Type Size
7 EX-101.SCH ipsc-20220930.xsd EX-101.SCH 67294
8 EX-101.CAL ipsc-20220930_cal.xml EX-101.CAL 73677
9 EX-101.DEF ipsc-20220930_def.xml EX-101.DEF 265178
10 EX-101.LAB ipsc-20220930_lab.xml EX-101.LAB 573094
11 EX-101.PRE ipsc-20220930_pre.xml EX-101.PRE 452326
90 EXTRACTED XBRL INSTANCE DOCUMENT ipsc-20220930x10q_htm.xml XML 1557070
Mailing Address 3675 MARKET STREET PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET PHILADELPHIA PA 19104 215-981-4000
Century Therapeutics, Inc. (Filer) CIK: 0001850119 (see all company filings)

IRS No.: 842040295 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40498 | Film No.: 221374949
SIC: 2836 Biological Products, (No Diagnostic Substances)